MedTrace Logo

Surgical Treatment of Pancreatic Metastases From Renal Cell Carcinoma

NCT04245410 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-11-03

No results posted yet for this study

Summary

Pancreatic metastases are a rare entity. In cases of metastatic renal carcinoma (RCC) it can present as isolated pancreatic metastasis, considering the possibility of surgical resection.

Goals:

* Define survival after resection of pancreatic cancer metastases renal in a wide range of our country.
* Identify predictive survival factors

Methods:

Retrospective multicenter study in which cases of pancreatic resection due to renal cancer metastases.

Conditions

  • Surgical Procedure
  • Disease Free Survival
  • Overall Survival

Sponsors & Collaborators

  • Universidad de Extremadura

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2022-03-01
Completion
2022-07-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04245410 on ClinicalTrials.gov